Teleflex (TFX) Announces Submission of Biologics License Application for Its Investigational Freeze Dried Plasma

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. GOOGL
6. APGE
7. DFTX
8. MU
9. IBM
10. HOOD

Go back to Teleflex (TFX) Announces Submission of Biologics License Application for Its Investigational Freeze Dried Plasma

Teleflex (TFX) Tops Q4 EPS by 20c, Revenues Beat; Offers FY21 EPS Outlook

February 25, 2021 6:36 AM EST

Teleflex (NYSE: TFX) reported Q4 EPS of $3.25, $0.20 better than the analyst estimate of $3.05. Revenue for the quarter came in at $711.2 million versus the consensus estimate of $687.66 million.

Fourth quarter 2020 revenues of $711.2 million, up 4.4% versus prior year period on an as-reported basis; up 2.3% on a constant currency basisFourth quarter 2020 GAAP diluted EPS from continuing operations of $1.62, compared to $2.28 in the prior year periodFourth quarter 2020 adjusted... More